Sandra Barbosa-Da-Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sandra Barbosa-Da-Silva has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Carlos Alberto Mandarim-De-Lacerda
Laboratory of Morphometry, Metabolism, and Cardiovascular disease, Biomedical Center, Institute of Biology, The University of the State of Rio de Janeiro, Rio de Janeiro, Brazil
5 shared publications - Vanessa Souza-Mello
Laboratory of Morphometry, Metabolism and Cardiovascular Diseases, Biomedical Center, Institute of Biology, Rio de Janeiro State University, Rio de Janeiro, Brazil
5 shared publications - Marcia Barbosa Aguila
Laboratory of Morphometry, Metabolism, and Cardiovascular disease, Biomedical Center, Institute of Biology, The University of the State of Rio de Janeiro, Rio de Janeiro, Brazil
4 shared publications - Luiz Eduardo Macedo Cardoso
Laboratory of Morphometry, Metabolism, and Cardiovascular Disease, Institute of Biology, Biomedical Center, State University of Rio de Janeiro, RJ, Brazil
2 shared publications - Tamiris Ingrid Petito-Da-Silva
Laboratory of Morphometry, Metabolism and Cardiovascular Disease, Institute of Biology The University of the State of Rio de Janeiro Rio de Janeiro Brazil
2 shared publications - Thatiany Souza Marinho
Laboratory of Morphometry, Metabolism, and Cardiovascular disease, Biomedical Center, Institute of Biology, The University of the State of Rio de Janeiro, Rio de Janeiro, Brazil
2 shared publications
Latest Publications
- Open Access
- 17 February 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (2) , e0342671
Persistence of the hepatic benefits of high-intensity interval training (HIIT) during detraining despite body weight regain in mice
High-intensity interval training (HIIT) is an effective intervention for improving metabolic health and mitigating metabolic dysfunction-associated steatotic liver disease (MASLD). Nonetheless, the stability of these benefits throughout detraining periods and upon weight regain remains inadequately characterized. This study aimed to evaluate whether hepatic improvements induced by HIIT are sustained during detraining, even after body weight regain. Eighty male C57BL/6 mice were fed either a control (10% fat) or a high-fat (HF) diet (50% fat) for 12 weeks. Following this period, the animals were allocated to groups subjected to continuous HIIT or intermittent training cycles (each lasting 3 weeks). The outcomes assessed included body mass (BM), glucose tolerance, lipid profiles, liver enzyme levels (aspartate aminotransferase and alanine aminotransferase), hepatic steatosis, and the expression profiles of genes associated with lipogenesis ( Srebf1 , Mlxpl, and Fas ), β-oxidation ( Ppara and Cpt1a ), and endoplasmic reticulum (ER) stress ( Atf4, Ddit3, and Gadd45 ). Compared with the sedentary HF-NT condition, continuous HIIT reduced BM and improved glucose tolerance. Intermittent training (HF-TNT, HF-NTN) preserved metabolic benefits and reduced triglyceride and cholesterol levels. Notably, hepatic steatosis was significantly alleviated in all training groups but persisted even after detraining. Additionally, HIIT downregulated the expression of lipogenic genes and upregulated the expression of genes involved in β-oxidation. The levels of markers indicating ER stress were attenuated by HIIT, with a sustained reduction during periods of detraining. HIIT-induced metabolic and hepatic improvements persist partially during detraining, despite weight regain. These findings underscore the therapeutic value of continued or periodically repeated physical training in mitigating the adverse effects of an HF diet and preventing the progression of metabolic disorders such as MASLD.
- 17 February 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (2) , e0342671
Open AccessPersistence of the hepatic benefits of high-intensity interval training (HIIT) during detraining despite body weight regain in mice
High-intensity interval training (HIIT) is an effective intervention for improving metabolic health and mitigating metabolic dysfunction-associated steatotic liver disease (MASLD). Nonetheless, the stability of these benefits throughout detraining periods and upon weight regain remains inadequately characterized. This study aimed to evaluate whether hepatic improvements induced by HIIT are sustained during detraining, even after body weight regain. Eighty male C57BL/6 mice were fed either a control (10% fat) or a high-fat (HF) diet (50% fat) for 12 weeks. Following this period, the animals were allocated to groups subjected to continuous HIIT or intermittent training cycles (each lasting 3 weeks). The outcomes assessed included body mass (BM), glucose tolerance, lipid profiles, liver enzyme levels (aspartate aminotransferase and alanine aminotransferase), hepatic steatosis, and the expression profiles of genes associated with lipogenesis ( Srebf1 , Mlxpl, and Fas ), β-oxidation ( Ppara and Cpt1a ), and endoplasmic reticulum (ER) stress ( Atf4, Ddit3, and Gadd45 ). Compared with the sedentary HF-NT condition, continuous HIIT reduced BM and improved glucose tolerance. Intermittent training (HF-TNT, HF-NTN) preserved metabolic benefits and reduced triglyceride and cholesterol levels. Notably, hepatic steatosis was significantly alleviated in all training groups but persisted even after detraining. Additionally, HIIT downregulated the expression of lipogenic genes and upregulated the expression of genes involved in β-oxidation. The levels of markers indicating ER stress were attenuated by HIIT, with a sustained reduction during periods of detraining. HIIT-induced metabolic and hepatic improvements persist partially during detraining, despite weight regain. These findings underscore the therapeutic value of continued or periodically repeated physical training in mitigating the adverse effects of an HF diet and preventing the progression of metabolic disorders such as MASLD.
- Open Access
- 1 January 2025
- Published by Even3
- Vol. 2, 1
IMPACTO DOS CICLOS DE TREINO E DESTREINO, OBTIDOS POR TREINAMENTO INTERVALADO DE ALTA INTENSIDADE (HIIT), NOS PARÂMETROS METABÓLICOS DE CAMUNDONGOS
Introdução: A obesidade é uma doença crônica progressiva com alta tendência a reincidência. O reganho de peso é comum após tentativa de perda de peso e é frequentemente atribuído à falta de adesão dos pacientes ao tratamento. Evidências experimentais mostraram que as tentativas voluntárias de perder peso ativam mecanismos biológicos potentes que tendem a interromper a perda de peso e restaurar o peso corporal anterior. A perda e recuperação de peso corporal levam a mudanças metabólicas, algumas das quais são prejudiciais. O ganho de peso após um período de perda pode contribuir para o desenvolvimento ou progressão da esteatose hepática, que é caracterizada pelo acúmulo de gordura nos hepatócitos. A prática de atividade física está entre as recomendações para o tratamento da esteatose hepática e da obesidade, entretanto, a falta de engajamento na prática de atividades físicas afeta o cumprimento do tratamento. Logo, a adoção do treinamento intervalado de alta intensidade (High-intensity interval training- HIIT) tornou-se promissora por oferecer melhoras expressivas no tratamento da esteatose hepática e de outras doenças associadas ao sobrepeso e obesidade, independente de perda de massa corporal. Porém, os efeitos da inconstância da rotina de treinos, na atenuação ou piora dos parâmetros de massa corporal, esteatose hepática e metabolismo de carboidratos ainda não estão claros. Objetivo: Estudar as alterações causadas após ciclos de treino e destreino sobre os parâmetros metabólicos em camundongos alimentados com uma dieta hiperlipídica. Métodos: Foram utilizados 80 camundongos C57Bl/6 machos, de 3 meses de idade (CEUA015/23), distribuídos inicialmente em 2 grupos (n=40, cada) e que receberam diferentes dietas por 12 semanas: dieta controle (C, 14% de proteína, 10% de gordura e 76% de carboidratos, energia total de 15KJ/g) ou dieta rica hiperlipídica (high fat, HF, 14% de proteína, 50% de gordura, e 36% de carboidratos, energia total de 21KJ/g). O conteúdo mineral e vitamínico das duas dietas respeitou a recomendação do American Institute of Nutrition (AIN 93M). Após, sem alteração de suas dietas, os grupos foram redivididos em 8 grupos de perfis não-treinados, treinados e os que ciclaram entre treino e nãotreino (fase HIIT, que durou 9 semanas). O HIIT era realizado 3 vezes por semana, em 3 ciclos (cada ciclo com 3 semanas) com variações de intensidade em ciclos de 3 minutos, sendo 1 minuto de baixa intensidade e 2 minutos de alta intensidade. Os animais que treinaram foram submetidos a testes de esforço no início, meio e fim do protocolo de treino para reajustes de intensidade. Ao fim da fase HIIT, houve o sacrifício dos animais, e os órgãos alvos foram dissecados.
- 1 January 2025
- Published by Even3
- Vol. 2, 1
Open AccessIMPACTO DOS CICLOS DE TREINO E DESTREINO, OBTIDOS POR TREINAMENTO INTERVALADO DE ALTA INTENSIDADE (HIIT), NOS PARÂMETROS METABÓLICOS DE CAMUNDONGOS
Introdução: A obesidade é uma doença crônica progressiva com alta tendência a reincidência. O reganho de peso é comum após tentativa de perda de peso e é frequentemente atribuído à falta de adesão dos pacientes ao tratamento. Evidências experimentais mostraram que as tentativas voluntárias de perder peso ativam mecanismos biológicos potentes que tendem a interromper a perda de peso e restaurar o peso corporal anterior. A perda e recuperação de peso corporal levam a mudanças metabólicas, algumas das quais são prejudiciais. O ganho de peso após um período de perda pode contribuir para o desenvolvimento ou progressão da esteatose hepática, que é caracterizada pelo acúmulo de gordura nos hepatócitos. A prática de atividade física está entre as recomendações para o tratamento da esteatose hepática e da obesidade, entretanto, a falta de engajamento na prática de atividades físicas afeta o cumprimento do tratamento. Logo, a adoção do treinamento intervalado de alta intensidade (High-intensity interval training- HIIT) tornou-se promissora por oferecer melhoras expressivas no tratamento da esteatose hepática e de outras doenças associadas ao sobrepeso e obesidade, independente de perda de massa corporal. Porém, os efeitos da inconstância da rotina de treinos, na atenuação ou piora dos parâmetros de massa corporal, esteatose hepática e metabolismo de carboidratos ainda não estão claros. Objetivo: Estudar as alterações causadas após ciclos de treino e destreino sobre os parâmetros metabólicos em camundongos alimentados com uma dieta hiperlipídica. Métodos: Foram utilizados 80 camundongos C57Bl/6 machos, de 3 meses de idade (CEUA015/23), distribuídos inicialmente em 2 grupos (n=40, cada) e que receberam diferentes dietas por 12 semanas: dieta controle (C, 14% de proteína, 10% de gordura e 76% de carboidratos, energia total de 15KJ/g) ou dieta rica hiperlipídica (high fat, HF, 14% de proteína, 50% de gordura, e 36% de carboidratos, energia total de 21KJ/g). O conteúdo mineral e vitamínico das duas dietas respeitou a recomendação do American Institute of Nutrition (AIN 93M). Após, sem alteração de suas dietas, os grupos foram redivididos em 8 grupos de perfis não-treinados, treinados e os que ciclaram entre treino e nãotreino (fase HIIT, que durou 9 semanas). O HIIT era realizado 3 vezes por semana, em 3 ciclos (cada ciclo com 3 semanas) com variações de intensidade em ciclos de 3 minutos, sendo 1 minuto de baixa intensidade e 2 minutos de alta intensidade. Os animais que treinaram foram submetidos a testes de esforço no início, meio e fim do protocolo de treino para reajustes de intensidade. Ao fim da fase HIIT, houve o sacrifício dos animais, e os órgãos alvos foram dissecados.
- 12 December 2023
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 68 (4) , e2300148
An Intestinal FXR Agonist Mitigates Dysbiosis, Intestinal Tight Junctions, and Inflammation in High‐Fat Diet‐Fed Mice
Scope: To analyze the effects of fexaramine (FEX), as an intestinal FXR agonist, on the modulation of the intestinal microbiota and ileum of mice fed a high‐fat (HF) diet.Methods and results: Three‐month‐old C57Bl/6 male mice are divided into two groups and received a control (C, 10% of energy from lipids) or HF (50% of energy from lipids) diet for 12 weeks. They are subdivided into the C, C + FEX, HF, and HF + FEX groups. FEX is administered (FEX‐5 mg kg−1) via orogastric gavage for three weeks. Body mass (BM), glucose metabolism, qPCR 16S rRNA gene expression, and ileum gene expression, bile acids (BAs), tight junctions (TJs), and incretin are analyzed. FEX reduces BM and glucose intolerance, reduces plasma lipid concentrations and the Firmicutes/Bacteroidetes ratio, increases the Lactobacillus sp. and Prevotella sp. abundance, and reduces the Escherichia coli abundance. Consequently, the ileal gene expression of Fxr‐Fgf15, Tgr5‐Glp1, and Cldn‐Ocldn‐Zo1 is increased, and Tlr4‐Il6‐Il1beta is decreased.Conclusion: FEX stimulates intestinal FXR and improves dysbiosis, intestinal TJs, and the release of incretins, mitigating glucose intolerance and BM increases induced by an HF diet. However, FEX results in glucose intolerance, insulin resistance, and reduces intestinal TJs in a control group, thus demonstrating limitations to this dietary model.
- 12 December 2023
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 68 (4) , e2300148
An Intestinal FXR Agonist Mitigates Dysbiosis, Intestinal Tight Junctions, and Inflammation in High‐Fat Diet‐Fed Mice
Scope: To analyze the effects of fexaramine (FEX), as an intestinal FXR agonist, on the modulation of the intestinal microbiota and ileum of mice fed a high‐fat (HF) diet.Methods and results: Three‐month‐old C57Bl/6 male mice are divided into two groups and received a control (C, 10% of energy from lipids) or HF (50% of energy from lipids) diet for 12 weeks. They are subdivided into the C, C + FEX, HF, and HF + FEX groups. FEX is administered (FEX‐5 mg kg−1) via orogastric gavage for three weeks. Body mass (BM), glucose metabolism, qPCR 16S rRNA gene expression, and ileum gene expression, bile acids (BAs), tight junctions (TJs), and incretin are analyzed. FEX reduces BM and glucose intolerance, reduces plasma lipid concentrations and the Firmicutes/Bacteroidetes ratio, increases the Lactobacillus sp. and Prevotella sp. abundance, and reduces the Escherichia coli abundance. Consequently, the ileal gene expression of Fxr‐Fgf15, Tgr5‐Glp1, and Cldn‐Ocldn‐Zo1 is increased, and Tlr4‐Il6‐Il1beta is decreased.Conclusion: FEX stimulates intestinal FXR and improves dysbiosis, intestinal TJs, and the release of incretins, mitigating glucose intolerance and BM increases induced by an HF diet. However, FEX results in glucose intolerance, insulin resistance, and reduces intestinal TJs in a control group, thus demonstrating limitations to this dietary model.
- Top Cited Papers
- 28 September 2022
- Published by Wiley in Cell Biochemistry and Function
- Vol. 40 (8) , 903-913
Semaglutide (GLP‐1 receptor agonist) stimulates browning on subcutaneous fat adipocytes and mitigates inflammation and endoplasmic reticulum stress in visceral fat adipocytes of obese mice
Semaglutide (GLP‐1 agonist) was approved for treating obesity. Although the effects on weight loss and metabolism are known, the responses of adipocytes to semaglutide are yet limited. C57BL/6 male mice (n = 20/group) were fed a control diet (C) or a high‐fat (HF) diet for 16 weeks and then separated into four groups (n = 10/group) for an additional four weeks: C, C diet and semaglutide, HF, and HF diet and semaglutide. Epididymal white adipose tissue (eWAT) and subcutaneous white adipose tissue (sWAT) fat pads were studied with biochemistry, immunohistochemistry/fluorescence, stereology, and reverse transcription‐quantitative polymerase chain reaction. In obese mice, semaglutide reduced the fat pad masses (eWAT, −55%; sWAT, −40%), plasmatic cytokines, and proinflammatory gene expressions: tumor necrosis factor‐alpha (−60%); interleukin (IL)‐6 (−55%); IL‐1 beta (−40%); monocyte chemoattractant protein‐1 (−90%); and leptin(−80%). Semaglutide also lessened endoplasmic reticulum (ER) stress genes of activating transcription factor‐4 (−85%), CCAAT enhancer‐binding protein homologous protein (−55%), and growth arrest and DNA damage‐inducible gene 45 (−45%). The obese mice's adipocyte hypertrophy and macrophage infiltration were equally reduced by semaglutide. Semaglutide enhanced multiloculation and uncoupled protein 1 (UCP1) labeling in obese mice: peroxisome proliferator‐activated receptor‐alpha (+560%) and gamma (+150%), fibronectin type III domain‐containing protein 5 (+215%), peroxisome proliferator‐activated receptor‐alpha coactivator (+110%), nuclear respiratory factor 1 (+260%), and mitochondrial transcription factor A (+120%). Semaglutide also increased thermogenetic gene expressions for the browning phenotype maintenance: beta‐3 adrenergic receptor (+520%), PR domain containing 16 (+90%), and Ucp1 (+110%). In conclusion, semaglutide showed significant beneficial effects beyond weight loss, directly on fat pads and adipocytes of obese mice, remarkably anti‐inflammatory, and reduced adipocyte size and ER stress. Besides, semaglutide activated adipocyte browning, improving UCP1, mitochondrial biogenesis, and thermogenic marker expressions help weight loss.
- 28 September 2022
- Published by Wiley in Cell Biochemistry and Function
- Vol. 40 (8) , 903-913
Top Cited PapersSemaglutide (GLP‐1 receptor agonist) stimulates browning on subcutaneous fat adipocytes and mitigates inflammation and endoplasmic reticulum stress in visceral fat adipocytes of obese mice
Semaglutide (GLP‐1 agonist) was approved for treating obesity. Although the effects on weight loss and metabolism are known, the responses of adipocytes to semaglutide are yet limited. C57BL/6 male mice (n = 20/group) were fed a control diet (C) or a high‐fat (HF) diet for 16 weeks and then separated into four groups (n = 10/group) for an additional four weeks: C, C diet and semaglutide, HF, and HF diet and semaglutide. Epididymal white adipose tissue (eWAT) and subcutaneous white adipose tissue (sWAT) fat pads were studied with biochemistry, immunohistochemistry/fluorescence, stereology, and reverse transcription‐quantitative polymerase chain reaction. In obese mice, semaglutide reduced the fat pad masses (eWAT, −55%; sWAT, −40%), plasmatic cytokines, and proinflammatory gene expressions: tumor necrosis factor‐alpha (−60%); interleukin (IL)‐6 (−55%); IL‐1 beta (−40%); monocyte chemoattractant protein‐1 (−90%); and leptin(−80%). Semaglutide also lessened endoplasmic reticulum (ER) stress genes of activating transcription factor‐4 (−85%), CCAAT enhancer‐binding protein homologous protein (−55%), and growth arrest and DNA damage‐inducible gene 45 (−45%). The obese mice's adipocyte hypertrophy and macrophage infiltration were equally reduced by semaglutide. Semaglutide enhanced multiloculation and uncoupled protein 1 (UCP1) labeling in obese mice: peroxisome proliferator‐activated receptor‐alpha (+560%) and gamma (+150%), fibronectin type III domain‐containing protein 5 (+215%), peroxisome proliferator‐activated receptor‐alpha coactivator (+110%), nuclear respiratory factor 1 (+260%), and mitochondrial transcription factor A (+120%). Semaglutide also increased thermogenetic gene expressions for the browning phenotype maintenance: beta‐3 adrenergic receptor (+520%), PR domain containing 16 (+90%), and Ucp1 (+110%). In conclusion, semaglutide showed significant beneficial effects beyond weight loss, directly on fat pads and adipocytes of obese mice, remarkably anti‐inflammatory, and reduced adipocyte size and ER stress. Besides, semaglutide activated adipocyte browning, improving UCP1, mitochondrial biogenesis, and thermogenic marker expressions help weight loss.
- Open Access
- 1 April 2022
- Published by FapUNIFESP (SciELO) in International braz j urol
- Vol. 48 (2) , 326-327
Vitamin D deficiency or insufficiency is associated with lower urinary tract symptoms
- 1 April 2022
- Published by FapUNIFESP (SciELO) in International braz j urol
- Vol. 48 (2) , 326-327
Open AccessVitamin D deficiency or insufficiency is associated with lower urinary tract symptoms
- Open Access
- 18 January 2022
- Published by SAGE Publications in Journal of the Renin-Angiotensin-Aldosterone System
- Vol. 2022, 8861911
Empagliflozin Alleviates Left Ventricle Hypertrophy in High-Fat-Fed Mice by Modulating Renin Angiotensin Pathway
Aims. The cardiobenefits of empagliflozin are multidimensional, and some mechanisms are still unclear. The aim of the present study was to evaluate the effect of treatment with empagliflozin on biometric parameters and gene expression in the local cardiac RAS, oxidative stress, and endoplasmic reticulum pathways in a mouse model. Main Methods. Forty male C57BL/6 mice were fed with control (C) or high-fat (HF) diets for 10 weeks. After that, the groups were redistributed according to the treatment with empagliflozinCE or HFE. The empagliflozin was administered via food for 5 weeks (10mg/kg/day). We performed biochemical analyses, blood pressure monitoring, oral glucose tolerance test, left ventricle (LV) stereology, RT-qPCR for genes related to classical and counterregulatory local RAS, oxidative stress, and endoplasmic reticulum stress. Key Findings. In comparison to HF, HFE decreased body mass and improved glucose intolerance and insulin resistance. The cardiac parameters were enhanced after treatment as expressed by decrease in plasma cholesterol, plasma uric acid, and systolic blood pressure. In addition, LV analysis showed that empagliflozin reduces cardiomyocyte area and LV thickness. The local RAS had less activity of the classical pathway and positive effects on the counterregulatory pathway. Empagliflozin treatment also decreased oxidative stress and endoplasmic reticulum stress-related genes. Significance. Our results suggests that empagliflozin modulates the local RAS pathway towards alleviation of oxidative stress and ER stress in the LV, which may be a route to its effects on improved cardiac remodeling.
- 18 January 2022
- Published by SAGE Publications in Journal of the Renin-Angiotensin-Aldosterone System
- Vol. 2022, 8861911
Open AccessEmpagliflozin Alleviates Left Ventricle Hypertrophy in High-Fat-Fed Mice by Modulating Renin Angiotensin Pathway
Aims. The cardiobenefits of empagliflozin are multidimensional, and some mechanisms are still unclear. The aim of the present study was to evaluate the effect of treatment with empagliflozin on biometric parameters and gene expression in the local cardiac RAS, oxidative stress, and endoplasmic reticulum pathways in a mouse model. Main Methods. Forty male C57BL/6 mice were fed with control (C) or high-fat (HF) diets for 10 weeks. After that, the groups were redistributed according to the treatment with empagliflozinCE or HFE. The empagliflozin was administered via food for 5 weeks (10mg/kg/day). We performed biochemical analyses, blood pressure monitoring, oral glucose tolerance test, left ventricle (LV) stereology, RT-qPCR for genes related to classical and counterregulatory local RAS, oxidative stress, and endoplasmic reticulum stress. Key Findings. In comparison to HF, HFE decreased body mass and improved glucose intolerance and insulin resistance. The cardiac parameters were enhanced after treatment as expressed by decrease in plasma cholesterol, plasma uric acid, and systolic blood pressure. In addition, LV analysis showed that empagliflozin reduces cardiomyocyte area and LV thickness. The local RAS had less activity of the classical pathway and positive effects on the counterregulatory pathway. Empagliflozin treatment also decreased oxidative stress and endoplasmic reticulum stress-related genes. Significance. Our results suggests that empagliflozin modulates the local RAS pathway towards alleviation of oxidative stress and ER stress in the LV, which may be a route to its effects on improved cardiac remodeling.
- Open Access
- 1 December 2021
- Published by FapUNIFESP (SciELO) in International braz j urol
- Vol. 47 (6) , 1148-1149
Editorial Comment: Effect of a low-calorie diet on 24-hour urinary parameters of obese adults with idiopathic calcium oxalate kidney stones
- 1 December 2021
- Published by FapUNIFESP (SciELO) in International braz j urol
- Vol. 47 (6) , 1148-1149
Open AccessEditorial Comment: Effect of a low-calorie diet on 24-hour urinary parameters of obese adults with idiopathic calcium oxalate kidney stones
- 1 December 2019
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 498, 110539
Empaglifozin mitigates NAFLD in high-fat-fed mice by alleviating insulin resistance, lipogenesis and ER stress
- 1 December 2019
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 498, 110539
Empaglifozin mitigates NAFLD in high-fat-fed mice by alleviating insulin resistance, lipogenesis and ER stress
- Open Access
- 1 June 2017
- Published by Elsevier in Biochimie Open
- Vol. 4, 19-30
Liver and Metformin: Lessons of a fructose diet in mice
- 1 June 2017
- Published by Elsevier in Biochimie Open
- Vol. 4, 19-30
Open AccessLiver and Metformin: Lessons of a fructose diet in mice